Interestingly, cell based studies demonstrated that TGF-β1 stimulation directly enhanced Endo180 expression in glioma cells (Figure 3), providing an explanation for the enhanced expression of Endo180 in GBMs. Here, TGFB1 is linked to central nervous system cancer.